Diagnostic Report: Final
Diagnostic Report: Final
Diagnostic Report: Final
HAEMATOLOGY
CBC WITH PS
BLOOD COUNTS,EDTA WHOLE BLOOD
HEMOGLOBIN (HB) 15.2 13.0 - 17.0 g/dL
RED BLOOD CELL (RBC) COUNT 4.27 Low 4.5 - 5.5 mil/µL
WHITE BLOOD CELL (WBC) COUNT 8.30 4.0 - 10.0 thou/µL
PLATELET COUNT 376 150 - 410 thou/µL
RBC AND PLATELET INDICES
HEMATOCRIT (PCV) 46.2 40 - 50 %
MEAN CORPUSCULAR VOLUME (MCV) 108.0 High 83 - 101 fL
MEAN CORPUSCULAR HEMOGLOBIN (MCH) 35.5 High 27.0 - 32.0 pg
MEAN CORPUSCULAR HEMOGLOBIN 32.8 31.5 - 34.5 g/dL
CONCENTRATION (MCHC)
RED CELL DISTRIBUTION WIDTH (RDW) 13.2 11.6 - 14.0 %
MENTZER INDEX 25.3
MEAN PLATELET VOLUME (MPV) 9.9 6.8 - 10.9 fL
WBC DIFFERENTIAL COUNT
NEUTROPHILS 47 40 - 80 %
LYMPHOCYTES 41 High 20 - 40 %
MONOCYTES 4 2 - 10 %
EOSINOPHILS 8 High 1-6 %
BASOPHILS 0 0-2 %
ABSOLUTE NEUTROPHIL COUNT 3.90 2.0 - 7.0 thou/µL
ABSOLUTE LYMPHOCYTE COUNT 3.40 High 1.0 - 3.0 thou/µL
ABSOLUTE MONOCYTE COUNT 0.33 0.2 - 1.0 thou/µL
ABSOLUTE EOSINOPHIL COUNT 0.66 High 0.02 - 0.50 thou/µL
ABSOLUTE BASOPHIL COUNT 0.00 Low 0.02 - 0.10 thou/µL
NEUTROPHIL LYMPHOCYTE RATIO (NLR) 40.7
PERIPHERAL SMEAR EXAM, EDTA WHOLE BLOOD
RBC PREDOMINANTLY NORMOCYTIC NORMOCHROMIC.
WBC TOTAL COUNT IS WITH IN NORMAL LIMIT.
DIFFERENTIAL COUNT SHOWS MILD EOSINOPHILS.
PLATELETS ADEQUATE.
NO HAEMOPARASITES SEEN.
Page 1 Of 6
Interpretation(s)
BLOOD COUNTS,EDTA WHOLE BLOOD-The cell morphology is well preserved for 24hrs. However after 24-48 hrs a progressive increase in MCV and HCT is observed leading
to a decrease in MCHC. A direct smear is recommended for an accurate differential count and for examination of RBC morphology.
RBC AND PLATELET INDICES-Mentzer index (MCV/RBC) is an automated cell-counter based calculated screen tool to differentiate cases of Iron deficiency anaemia(>13)
from Beta thalassaemia trait
(<13) in patients with microcytic anaemia. This needs to be interpreted in line with clinical correlation and suspicion. Estimation of HbA2 remains the gold standard for
diagnosing a case of beta thalassaemia trait.
WBC DIFFERENTIAL COUNT-The optimal threshold of 3.3 for NLR showed a prognostic possibility of clinical symptoms to change from mild to severe in COVID positive
patients. When age = 49.5 years old and NLR = 3.3, 46.1% COVID-19 patients with mild disease might become severe. By contrast, when age < 49.5 years old and NLR <
3.3, COVID-19 patients tend to show mild disease.
(Reference to - The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients A.-P. Yang, et al. International Immunopharmacology 84 (2020) 106504
This ratio element is a calculated parameter and out of NABL scope.
Page 2 Of 6
BIO CHEMISTRY
LIPID PROFILE, SERUM
CHOLESTEROL, TOTAL 181 Desirable: < 200 mg/dL
BorderlineHigh: 200 - 239
High: > or = 240
TRIGLYCERIDES 247 High Desirable: < 150 mg/dL
BorderlineHigh: 150 - 199
High: 200 - 499
Very High: > or = 500
HDL CHOLESTEROL 34 Low Low < 40 mg/dL
High > or = 60
LDL CHOLESTEROL, DIRECT 136 High Optimal: < 100 mg/dL
NearOptimal/AboveOptimal:
100 - 129
BorderlineHigh: 130 - 159
High: 160 - 189
VeryHigh: = 190
NON HDL CHOLESTEROL 147 High Desirable: Less than 130 mg/dL
Above Desirable: 130 - 159
Borderline High: 160 - 189
High: 190 - 219
Very high: > or = 220
CHOL/HDL RATIO 5.3 High 3.3 - 4.4 Low Risk
4.5-7.0 Average Risk
7.1 - 11.0 Moderate Risk
> 11.0 High Risk
LDL/HDL RATIO 4.0 High 0.5 - 3.0 Desirable/ Low Risk
3.1-6.0 Borderline /Moderate Risk
> 6.0 High Risk
VERY LOW DENSITY LIPOPROTEIN 49.4 High 12 - 30 mg/dL
Interpretation(s)
Page 3 Of 6
Page 4 Of 6
**End Of Report**
Please visit www.srlworld.com for related Test Information for this accession
Page 5 Of 6
Page 6 Of 6